| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50242-877-01 | 50242-877 | HUMAN PRESCRIPTION DRUG | Xofluza | BALOXAVIR MARBOXIL | TABLET, FILM COATED | ORAL | 20210326 | N/A | NDA | NDA210854 | Genentech, Inc. | BALOXAVIR MARBOXIL | 80 mg/1 | 1 BLISTER PACK in 1 CARTON (50242-877-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
| 50242-877-86 | 50242-877 | HUMAN PRESCRIPTION DRUG | Xofluza | BALOXAVIR MARBOXIL | TABLET, FILM COATED | ORAL | 20210831 | N/A | NDA | NDA210854 | Genentech, Inc. | BALOXAVIR MARBOXIL | 80 mg/1 | 1 BLISTER PACK in 1 CARTON (50242-877-86) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
| 50242-860-86 | 50242-860 | HUMAN PRESCRIPTION DRUG | Xofluza | BALOXAVIR MARBOXIL | TABLET, FILM COATED | ORAL | 20210831 | N/A | NDA | NDA210854 | Genentech, Inc. | BALOXAVIR MARBOXIL | 40 mg/1 | 1 BLISTER PACK in 1 CARTON (50242-860-86) / 1 TABLET, FILM COATED in 1 BLISTER PACK |
| 50242-860-01 | 50242-860 | HUMAN PRESCRIPTION DRUG | Xofluza | BALOXAVIR MARBOXIL | TABLET, FILM COATED | ORAL | 20210326 | N/A | NDA | NDA210854 | Genentech, Inc. | BALOXAVIR MARBOXIL | 40 mg/1 | 1 BLISTER PACK in 1 CARTON (50242-860-01) / 1 TABLET, FILM COATED in 1 BLISTER PACK |